Literature DB >> 17000

Alpha blocking action of the antihypertensive agent, prazosin.

R M Graham, H F Oates, L M Stoker, G S Stokes.   

Abstract

The vasodilatory and alpha adrenergic blocking properties of prazosin were studied in anesthetized rats and compared with the direct-acting vasodilator, diazoside. The hypotensive activity of diazoxide was unimpaired after ganglion blockade with pentolinium or alpha adrenoreceptor blockade with phentolamine; diazoxide also significantly attenuated angiotensin II pressor responses. In contrast, the hypotensive action of prazosin was completely abolished, over a 10(4)-fold dose range, after ganglion or alpha adrenoreceptor blockade, and this agent failed, even in maximal hypotensive doses, to attenuate angiotensin II pressor responses. In addition, prazosin was shown to possess potent alpha adrenoreceptor blocking properties, significantly attenuating norepinephrine pressor responses and causing reversal of epinephrine pressor responses. These studies in the rat indicate that the hypotensive action of prazosin is not due to a direct relaxant effect upon vascular smooth muscle, but is attributable to alpha adrenoreceptor blockade.

Entities:  

Mesh:

Substances:

Year:  1977        PMID: 17000

Source DB:  PubMed          Journal:  J Pharmacol Exp Ther        ISSN: 0022-3565            Impact factor:   4.030


  16 in total

1.  Haemodynamic effects of dicentrine, a novel alpha 1-adrenoceptor antagonist: comparison with prazosin in spontaneously hypertensive and normotensive Wistar-Kyoto rats.

Authors:  S M Yu; S Y Hsu; F N Ko; C C Chen; Y L Huang; T F Huang; C M Teng
Journal:  Br J Pharmacol       Date:  1992-08       Impact factor: 8.739

Review 2.  Prazosin: a review of its pharmacological properties and therapeutic efficacy in hypertension.

Authors:  R N Brogden; R C Heel; T M Speight; G S Avery
Journal:  Drugs       Date:  1977-09       Impact factor: 9.546

3.  Effects of prazosin and two of its derivatives (UK 18.596 and UK 33.274) on alpha-adrenoceptors [proceedings].

Authors:  F K Ali; S P Kossen; P B Timmermans; P A Van Zwieten
Journal:  Br J Pharmacol       Date:  1980-01       Impact factor: 8.739

4.  R 28935 and prazosin: effects on central and peripheral alpha-adrenoreceptor activity and on blood pressure.

Authors:  N E Andén; C Gomes; B Persson; G Trolin
Journal:  Naunyn Schmiedebergs Arch Pharmacol       Date:  1978-05       Impact factor: 3.000

5.  Evaluation of activity inotropic of a new steroid derivative using an isolated rat heart model.

Authors:  Figueroa-Valverde Lauro; Díaz-Cedillo Francisco; García-Cervera Elodia; Pool-Gómez Eduardo; López-Ramos Maria; Rosas-Nexticapa Marcela; Hau-Heredia Lenin; Sarabia-Alcocer Bety; Campos-Ramos Landy
Journal:  Int J Clin Exp Med       Date:  2014-05-15

Review 6.  The pump, the exchanger, and the holy spirit: origins and 40-year evolution of ideas about the ouabain-Na+ pump endocrine system.

Authors:  Mordecai P Blaustein
Journal:  Am J Physiol Cell Physiol       Date:  2017-11-07       Impact factor: 4.249

7.  Pharmacological evidence for a functional role of the prejunctional alpha-adrenoreceptor in noradrenergic neurotransmission in the conscious rat.

Authors:  R M Graham; W H Stephenson; W A Pettinger
Journal:  Naunyn Schmiedebergs Arch Pharmacol       Date:  1980-03       Impact factor: 3.000

8.  Studies on the clinical pharmacology of prazosin. I: Cardiovascular, catecholamine and endocrine changes following a single dose.

Authors:  P C Rubin; T F Blaschke
Journal:  Br J Clin Pharmacol       Date:  1980-07       Impact factor: 4.335

9.  Prazosin depression of baroreflex function in hypertensive man.

Authors:  E H Sasso; D T O'Connor
Journal:  Eur J Clin Pharmacol       Date:  1982       Impact factor: 2.953

10.  Effect of nicotine on blood flow, oxygen consumption and glucose uptake in the canine small intestine.

Authors:  J Grayson; D D Oyebola
Journal:  Br J Pharmacol       Date:  1985-08       Impact factor: 8.739

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.